Beckman Coulter Life Sciences helps labs comply with looming deadline

NEWS RELEASE: Beckman Coulter Life Sciences Leading the Way to Help Labs Comply  with Confidence for Upcoming Annex 1 Regulation Deadline

Revised Annex 1 Takes Effect August 25, 2023

The Met One 3400+ Series portable airborne particle counter for cleanroom monitoring [Photo courtesy of Beckman Coulter Life Sciences]

INDIANAPOLIS – (July 24, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues its relentless commitment to providing laboratories of all sizes with individualized and tailored support to meet the evolving list of regional and global compliance requirements.

Cleanroom laboratories manufacturing sterile medicinal products in the European Union (EU) must make critical changes by August 25, 2023 to ensure Annex 1 Regulation compliance. This is a substantial update to the initial version released in 2008 an…

Read more
  • 0

Beckman Coulter Life Sciences to present NGS technologies at American Society of Human Genetics Annual Meeting

Lab automation company Beckman Coulter Life Sciences has announced that it will return to the American Society of Human Genetics (ASHG) annual meeting on October 25-29 in Los Angeles to display its NGS technologies.

At booth 2037, the company will showcase its instruments and provide one-on-one demonstrations to demonstrate how its technologies can optimize next-generation sequencing (NGS) workflows in low- to high-throughput labs.

At ASHG, the company will explain its vision for how to boost the efficiency of NGS automation at a range of reaction volumes. It will also demonstrate how its technology can automate workflows and generate high-quality sequencing data.

Beckman Coulter Life Sciences will display its NGS suite, including the Biomek NGeniuS Next Generation Library Prep System, the Echo 525 Acoustic Liquid Handler and the Biomek i5 Automated Workstation. The company will also showcase its NGS cleanup reagents and the EMnetik System for plasmid pr…

Read more
  • 0

Beckman Coulter Life Sciences snatches up ValitaCell

The lab automation company Beckman Coulter Life Sciences has acquired the Dublin, Ireland–based biotech company ValitaCell.

ValitaCell specializes in developing analytical technologies based on rich cell data to reduce the cost of commercializing new therapeutics.

ValitaCell  boasts that its ValitaTiter product fares better than other industry IgG quantification assays in terms of speed and ease of use. ValitaCell also claims that ValitaTiter has several advantages over techniques such as ELISA and HPLC.

“ValitaCell has a proven record for delivering innovative products and we are excited to build upon our successful partnership with Beckman Coulter Life Sciences,” said Dr. Jerry Clifford, Co-Founder and CEO of ValitaCell, in a news release. “Together with Beckman Coulter Life Sciences, we will advance our shared ambition to accelerate and enable the sustainable manufacture of innovative biological medicines to bring them to market faster.”


Read more
  • 0

Beckman Coulter Life Sciences names Suzanne Foster as president 

Lab automation specialist Beckman Coulter Life Sciences has appointed Cardinal Health veteran Suzanne Foster as president.

Foster served as Cardinal Health’s President Health-at-Home subsidiary from January 2020 to March 2022.

She has more than 25 years of experience in the healthcare industry, and also sits on the boards of several companies.

Foster has also served as the Stanley Black & Decker’s president of healthcare and worked for ten years as the general manager of Medtronic’s advanced energy unit.

“I believe a significant step forward can be made by evolving workflows,” Foster wrote in an email. “Finding solutions that make things as clear, accurate, and efficient as possible will certainly make the workload on laboratory staff more manageable.”

Suzanne Foster

Foster noted that she has repeatedly heard the topic of automation come up in conversations with customer…

Read more
  • 0

Good-bye outsourcing, hello in-house science: how innovation is giving scientists more control at the bench

The CytoFLEX SRT is a benchtop cell sorter from Beckman Coulter.

Ten years ago, as a Ph.D. student fellow at Indiana University studying the evolution of prokaryotes, the cheapest and easiest way for me to sequence some microbes was to send them halfway around the world to China. Even with quick shipping and no problems with the sequencing, it could take up to a month for me to see results. I was sure there had to be a better way, but with existing instruments, I had no idea what that would be.

Now, as a product manager at Beckman Coulter Life Sciences, I can say that a range of technological advancements means that researchers can conduct their experiments at their own bench. Improved automation in the form of robot arms and liquid handlers, as well as better software and user interfaces, make it possible to readily handle once-complicated tasks like library prep and cell sorting in-house without years of t…

Read more
  • 0

Beckman Coulter Life Sciences wins IVDR for flow cytometry reagents

Image courtesy of Beckman Coulter

Beckman Coulter Life Sciences (Indianapolis) has received an EU Quality Management System Certificate under the In Vitro Diagnostic Medical Devices Regulation 2017/746 (IVDR) for more than 200 flow cytometry reagents manufactured at its Marseille, France facility.

In May 2022, IVDR 2017/746 will replace the In Vitro Diagnostics Directive (98/79/EC) (IVDD), which has been in place since 1993.

Beckman Coulter Life Sciences notes that it has prepared for IVDR 2022 for more than four years, enlisting multiple teams in the effort.

“We have worked to ensure our existing CE-IVD portfolio, including reagents, kits, software and instruments remain compliant to meet the new regulation,” said Dr. Mario Koksch, vice president and general manager of the company’s flow cytometry business unit. “As IVDR compliance also requires significant effort from individual laboratories,…

Read more
  • 0